Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Andrew A House¹, Christoph Wanner², Mark J Sarnak³, Ileana L Piña⁴, Christopher W McIntyre⁵, Paul Komenda⁶, Bertram L Kasiske⁷, Anita Deswal⁸, Christopher R deFilippi⁹, John G F Cleland¹⁰, Stefan D Anker¹¹, Charles A Herzog¹², Michael Cheung¹³, David C Wheeler¹⁴, Wolfgang C Winkelmayer¹⁵, Peter A McCullough¹⁶; Conference Participants

Collaborators, Affiliations

Collaborators

Conference Participants:
Ali K Abu-Alfa, Kerstin Amann, Kazutaka Aonuma, Lawrence J Appel, Colin Baigent, George L Bakris, Debasish Banerjee, John N Boletis, Biykem Bozkurt, Javed Butler, Christopher T Chan, Maria Rosa Costanzo, Ruth F Dubin, Gerasimos Filippatos, Betty M Gikonyo, Dan K Gikonyo, Roger J Hajjar, Kunitoshi Iseki, Hideki Ishii, Greg A Knoll, Colin R Lenihan, Krista L Lentine, Edgar V Lerma, Etienne Macedo, Patrick B Mark, Eisei Noiri, Alberto Palazzuoli, Roberto Pecoits-Filho, Bertram Pitt, Claudio Rigatto, Patrick Rossignol, Soko Setoguchi, Manish M Sood, Stefan Störk, Rita S Suri, Karolina Szummer, Sydney C W Tang, Navdeep Tangri, Aliza Thompson, Krishnaswami Vijayaraghavan, Michael Walsh, Angela Yee-Moon Wang, Matthew R Weir

Affiliations

¹ Division of Nephrology, Department of Medicine, Western University and London Health Sciences Centre, London, Ontario, Canada. Electronic address: andrew.house@lhsc.on.ca.
² Department of Medicine, Division of Nephrology, University Hospital of Würzburg, Würzburg, Germany.
³ Department of Medicine, Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA.
⁴ Division of Cardiology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, USA.
⁵ Division of Nephrology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.
⁶ Department of Internal Medicine, Section of Nephrology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; Department of Medicine, Seven Oaks General Hospital, University of Manitoba, Winnipeg, Manitoba, Canada; Department of Community Health Sciences, Seven Oaks General Hospital, University of Manitoba, Winnipeg, Manitoba, Canada.
⁷ Hennepin County Medical Center, Minneapolis, Minnesota, USA.
⁸ Section of Cardiology, Michael E. DeBakey Veteran Affairs Medical Center, Houston, Texas, USA; Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
⁹ Inova Heart and Vascular Institute, Falls Church, Virginia, USA.
¹⁰ Robertson Centre for Biostatistics and Clinical Trials, University of Glasgow, Glasgow, UK; National Heart and Lung Institute, Imperial College, London, UK.
¹¹ Division of Cardiology and Metabolism, Department of Cardiology (CVK), Charité - Universitätsmedizin Berlin, Berlin, Germany; Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité - Universitätsmedizin Berlin, Berlin, Germany; Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK, German Centre for Cardiovascular Research), Charité - Universitätsmedizin Berlin, Berlin, Germany.
¹² Division of Cardiology, Department of Medicine, Hennepin County Medical Center and University of Minnesota, Minneapolis, Minnesota, USA; Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota, USA.
¹³ KDIGO, Brussels, Belgium.
¹⁴ University College London, London, UK.
¹⁵ Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
¹⁶ Department of Internal Medicine, Division of Cardiology, Baylor University Medical Center, Dallas, Texas, USA; Department of Internal Medicine, Division of Cardiology, Baylor Heart and Vascular Institute, Dallas, Texas, USA. Electronic address: peteramccullough@gmail.com.

PMID: 31053387
DOI: 10.1016/j.kint.2019.02.022

Free article

Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Andrew A House et al. Kidney Int. 2019 Jun.

Free article

. 2019 Jun;95(6):1304-1317.

doi: 10.1016/j.kint.2019.02.022. Epub 2019 Apr 30.

Authors

Collaborators

Conference Participants:
Ali K Abu-Alfa, Kerstin Amann, Kazutaka Aonuma, Lawrence J Appel, Colin Baigent, George L Bakris, Debasish Banerjee, John N Boletis, Biykem Bozkurt, Javed Butler, Christopher T Chan, Maria Rosa Costanzo, Ruth F Dubin, Gerasimos Filippatos, Betty M Gikonyo, Dan K Gikonyo, Roger J Hajjar, Kunitoshi Iseki, Hideki Ishii, Greg A Knoll, Colin R Lenihan, Krista L Lentine, Edgar V Lerma, Etienne Macedo, Patrick B Mark, Eisei Noiri, Alberto Palazzuoli, Roberto Pecoits-Filho, Bertram Pitt, Claudio Rigatto, Patrick Rossignol, Soko Setoguchi, Manish M Sood, Stefan Störk, Rita S Suri, Karolina Szummer, Sydney C W Tang, Navdeep Tangri, Aliza Thompson, Krishnaswami Vijayaraghavan, Michael Walsh, Angela Yee-Moon Wang, Matthew R Weir

Affiliations

¹ Division of Nephrology, Department of Medicine, Western University and London Health Sciences Centre, London, Ontario, Canada. Electronic address: andrew.house@lhsc.on.ca.
² Department of Medicine, Division of Nephrology, University Hospital of Würzburg, Würzburg, Germany.
³ Department of Medicine, Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA.
⁴ Division of Cardiology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, USA.
⁵ Division of Nephrology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.
⁶ Department of Internal Medicine, Section of Nephrology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; Department of Medicine, Seven Oaks General Hospital, University of Manitoba, Winnipeg, Manitoba, Canada; Department of Community Health Sciences, Seven Oaks General Hospital, University of Manitoba, Winnipeg, Manitoba, Canada.
⁷ Hennepin County Medical Center, Minneapolis, Minnesota, USA.
⁸ Section of Cardiology, Michael E. DeBakey Veteran Affairs Medical Center, Houston, Texas, USA; Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
⁹ Inova Heart and Vascular Institute, Falls Church, Virginia, USA.
¹⁰ Robertson Centre for Biostatistics and Clinical Trials, University of Glasgow, Glasgow, UK; National Heart and Lung Institute, Imperial College, London, UK.
¹¹ Division of Cardiology and Metabolism, Department of Cardiology (CVK), Charité - Universitätsmedizin Berlin, Berlin, Germany; Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité - Universitätsmedizin Berlin, Berlin, Germany; Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK, German Centre for Cardiovascular Research), Charité - Universitätsmedizin Berlin, Berlin, Germany.
¹² Division of Cardiology, Department of Medicine, Hennepin County Medical Center and University of Minnesota, Minneapolis, Minnesota, USA; Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota, USA.
¹³ KDIGO, Brussels, Belgium.
¹⁴ University College London, London, UK.
¹⁵ Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
¹⁶ Department of Internal Medicine, Division of Cardiology, Baylor University Medical Center, Dallas, Texas, USA; Department of Internal Medicine, Division of Cardiology, Baylor Heart and Vascular Institute, Dallas, Texas, USA. Electronic address: peteramccullough@gmail.com.

PMID: 31053387
DOI: 10.1016/j.kint.2019.02.022

Abstract

The incidence and prevalence of heart failure (HF) and chronic kidney disease (CKD) are increasing, and as such a better understanding of the interface between both conditions is imperative for developing optimal strategies for their detection, prevention, diagnosis, and management. To this end, Kidney Disease: Improving Global Outcomes (KDIGO) convened an international, multidisciplinary Controversies Conference titled Heart Failure in CKD. Breakout group discussions included (i) HF with preserved ejection fraction (HFpEF) and nondialysis CKD, (ii) HF with reduced ejection fraction (HFrEF) and nondialysis CKD, (iii) HFpEF and dialysis-dependent CKD, (iv) HFrEF and dialysis-dependent CKD, and (v) HF in kidney transplant patients. The questions that formed the basis of discussions are available on the KDIGO website http://kdigo.org/conferences/heart-failure-in-ckd/, and the deliberations from the conference are summarized here.

Keywords: cardiovascular disease; chronic kidney disease; congestive heart failure; hemodialysis; transplantation.

PubMed Disclaimer

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Enlighten: Publications, University of Glasgow - Access Free Full Text
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Collaborators

Affiliations

Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Authors

Collaborators

Affiliations

Abstract

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Research Materials

Miscellaneous